Two Sigma Investments, LP Dynavax Technologies Corp Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 866,356 shares of DVAX stock, worth $11.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
866,356
Previous 794,781 9.01%
Holding current value
$11.8 Million
Previous $8.85 Million 24.96%
% of portfolio
0.03%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$10.28 - $13.66 $735,791 - $977,714
71,575 Added 9.01%
866,356 $11.1 Million
Q3 2024

Nov 14, 2024
BUY
$10.05 - $11.61 $5.56 Million - $6.42 Million
552,877 Added 228.55%
794,781 $8.85 Million
Q2 2024

Aug 14, 2024
BUY
$10.73 - $12.58 $1.16 Million - $1.36 Million
108,095 Added 80.78%
241,904 $2.72 Million
Q1 2024

May 15, 2024
SELL
$11.7 - $14.98 $112,004 - $143,403
-9,573 Reduced 6.68%
133,809 $1.66 Million
Q4 2023

Feb 14, 2024
SELL
$13.09 - $14.98 $373,640 - $427,589
-28,544 Reduced 16.6%
143,382 $2 Million
Q3 2023

Nov 14, 2023
SELL
$12.64 - $14.99 $4.62 Million - $5.48 Million
-365,272 Reduced 68.0%
171,926 $2.54 Million
Q2 2023

Aug 14, 2023
SELL
$9.85 - $13.17 $1.57 Million - $2.1 Million
-159,200 Reduced 22.86%
537,198 $6.94 Million
Q1 2023

May 15, 2023
BUY
$9.44 - $11.88 $5.22 Million - $6.57 Million
553,235 Added 386.44%
696,398 $6.83 Million
Q4 2022

Feb 14, 2023
SELL
$10.27 - $13.29 $2.47 Million - $3.2 Million
-240,409 Reduced 62.68%
143,163 $1.52 Million
Q3 2022

Nov 14, 2022
SELL
$9.93 - $17.44 $7.38 Million - $13 Million
-743,172 Reduced 65.96%
383,572 $4 Million
Q2 2022

Aug 15, 2022
SELL
$7.45 - $12.83 $1.79 Million - $3.08 Million
-240,112 Reduced 17.57%
1,126,744 $14.2 Million
Q1 2022

May 16, 2022
BUY
$9.75 - $14.44 $3.42 Million - $5.07 Million
350,812 Added 34.53%
1,366,856 $14.8 Million
Q4 2021

Feb 14, 2022
SELL
$13.17 - $20.94 $14.1 Million - $22.5 Million
-1,072,359 Reduced 51.35%
1,016,044 $14.3 Million
Q3 2021

Nov 15, 2021
BUY
$9.16 - $19.83 $7.41 Million - $16 Million
808,853 Added 63.21%
2,088,403 $40.1 Million
Q2 2021

Aug 16, 2021
BUY
$7.25 - $10.99 $6.47 Million - $9.81 Million
892,790 Added 230.84%
1,279,550 $12.6 Million
Q1 2021

May 17, 2021
SELL
$4.57 - $11.18 $177,928 - $435,282
-38,934 Reduced 9.15%
386,760 $3.8 Million
Q4 2020

Feb 16, 2021
SELL
$3.73 - $5.6 $3.25 Million - $4.88 Million
-872,023 Reduced 67.2%
425,694 $1.89 Million
Q3 2020

Nov 16, 2020
BUY
$4.32 - $11.7 $3.75 Million - $10.2 Million
868,605 Added 202.42%
1,297,717 $5.61 Million
Q2 2020

Aug 14, 2020
BUY
$2.94 - $9.1 $1.26 Million - $3.9 Million
429,112 New
429,112 $3.81 Million

Others Institutions Holding DVAX

# of Institutions
288
Shares Held
131M
Call Options Held
507K
Put Options Held
374K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.72B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email